Nazivin Sensitive Spray nasal., Dosage 11.25mkg / dose, 10ml, # 1

Dosage form

Dosed nasal spray

Structure

Nazivin Sensitive 11.25 μg / dose - Oxymetazoline hydrochloride 0.250 mg

Excipients:

Citric acid monohydrate 0.609 mg

Sodium citrate dihydrate 3.823 mg

Glycerol (85%) 24.921 mg

Purified water 978.397 mg (for 11.25 μg / dose)

pharmachologic effect

Nazivin Sensitiv (oxymetazoline) has a vasoconstrictor effect.

When applied topically to the inflamed mucous membrane of the nasal cavity, it reduces swelling and nasal discharge.

Restores nasal breathing.

Elimination of edema of the nasal mucosa helps to restore aeration of the paranasal sinuses, the middle ear cavity, which reduces the likelihood of bacterial complications (sinusitis, sinusitis, otitis media).

With local intranasal application in therapeutic concentrations, it does not irritate and does not cause hyperemia of the nasal mucosa.

Oxymetazoline begins to act quickly, within a few minutes.

The duration of action of Nazivin Sensitiv is up to 12 hours.

Pharmacokinetics

With local intranasal application, oxymetazoline does not possess

systemic action.

The half-life of oxymetazoline with its intranasal

the introduction is 35 hours 2.1% of oxymetazoline is excreted in the urine and about 1.1% in the feces

Side effects

Sometimes: burning or dryness of the nasal mucosa, sneezing.

In rare cases: after the effect of using Nazivin Sensitiv has passed, a strong feeling of stuffiness" of the nose (reactive hyperemia).

Rarely: increased blood pressure, headache, dizziness, palpitations, tachycardia, anxiety, irritability, sleep disturbance (in children), nausea, insomnia, exanthema, visual impairment (if it gets into the eyes).

Long-term continuous use of vasoconstrictor drugs can lead to tachyphylaxis, atrophy of the nasal mucosa, and recurrent edema of the nasal mucosa (rhinitis medicamentosa).

Selling features

Available without a prescription

Special conditions

Carefully

With increased intraocular pressure, chronic heart failure, arterial hypertension, angina pectoris

arrhythmias, chronic renal failure, in patients with prostatic hyperplasia with clinical symptoms (urinary retention), severe atherosclerosis, hyperthyroidism, diabetes mellitus, pheochromocytoma.

Avoid contact with eyes.

To avoid the spread of infection, it is necessary to apply the drug individually.

Indications

- colds or viral infections of the upper respiratory tract, accompanied by a runny nose, sinusitis, eustachitis, otitis media, rhinitis of any etiology

- to eliminate edema before diagnostic manipulations in the nasal passages.

Contraindications

Atrophic rhinitis

angle-closure glaucoma

hypersensitivity to the components of the drug.

For Nazivin Sensitive nasal spray dosed 11.25 mcg / dose - children up to 1 year old.

Drug interactions

Slows down the absorption of local anesthetic drugs, lengthens their action.

In patients taking monoamine oxidase inhibitors (MAO) within the previous 2 weeks and within 2 weeks after their cancellation, tricyclic antidepressants or other drugs that increase blood pressure - an increase in blood pressure.

The co-administration of other vasoconstrictor drugs increases the risk of side effects.

Dosage

Nazivin Sensitiv nasal spray dosed at 11.25 mcg / dose is intended for nasal administration.

Children aged 1 to 6 years: 1 injection of Nazivin Sensitiv nasal spray dosed 11.25 mcg / dose into each nostril 2 - 3 times a day.

The drug is used for 5-7 days

Name ENG

NASIVIN SENSITIVE

Clinical and pharmacological group

A vasoconstrictor drug for local use in ENT practice

ATX code

Oxymetazoline

Dosage

11.25mcg / dose x 10ml

Structure

Citric acid monohydrate 0.609 mg, sodium citrate dihydrate 3.823 mg, glycerol (85%) 24.921 mg, purified water 978.397 mg (for 11.25 μg / dose).

Indications

Acute rhinitis (including allergic), vasomotor rhinitis, paranasal sinusitis, eustachitis, otitis media.

Narrowing of the vessels of the mucous membrane for diagnostic purposes (under medical supervision).

Storage conditions and periods

At a temperature not higher than 30 degrees.

Expiration date: 3 years

INN / Active ingredient

Oxymetazoline

Contraindications

Hypersensitivity to drug components

atrophic rhinitis

angle-closure glaucoma

children's age up to 1 year.

With care: severe cardiovascular diseases, severe metabolic disorders.

Specifications

Category

Runny nose

Scope of the drug

Ear, Throat, Nose

Release form

Spray

Manufacturer country

Spain

Package quantity, pcs

one

Scope of application

Virology

Minimum age from

1 year

Way of introduction

Through the respiratory tract

Vacation conditions

Without recipe

Volume, ml.

10 ml

Brand name

Takeda

The amount of the dosage form in the primary package

10 ml

Primary packaging type

Bottle

Type of consumer packaging

Pack of cardboard

Pharmaco-therapeutic group

Decongestant - alpha adrenergic agonist

Anatomical and therapeutic characteristics

R01AA05 Oxymetazoline

Dosage form

Dosed nasal spray

Expiration date in days

1095

The target audience

Children

Dosage (volume) of the substance in the preparation

oxymetazoline hydrochloride 11.25 mcg

Package weight, g

25

Mode of application

:

Children aged 1 to 6 years: 1 injection of Nazivin Sensitiv nasal spray dosed 11.25 mcg / dose into each nostril 2 - 3 times a day.

Information on technical characteristics, delivery set, country of manufacture "